Detection of the most dangerous HPV-16 and HPV-18 types predicted high-grade cervical intraepithelial neoplasia with 92% sensitivity compared with cytology's 53.
What does HGCIN stand for?
HGCIN stands for High-Grade Cervical Intraepithelial Neoplasia (human papillomavirus)
This definition appears rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Human Genome Coordinating Committee
- Humanities Graduate Conference Committee (Utah)
- Helen Gordon Child Development Center (Portland State University, OR)
- Historians of German and Central European Art
- Harold Grinspoon Charitable Foundation
- Hutchison Global Communications Holdings (Hong Kong)
- Hansen Gray & Company, Inc.
- Harvard Green Campus Initiative
- Houston Gulf Coast Irrigation Association (Texas)
- Harrison Grierson Consultants Limited (civil engineering; Auckland, New Zealand)
- Human Germ Cell-Less Expression (fertility)
- Human Glioma-Derived Cell Lines (biology)
- Hughes Communications Inc (stock symbol)
- Holy Gardens Calapan Memorial Park (Philippines)
- Hercules Graphics Card Plus
- High-Grade Cribriform Prostatic Intraepithelial Neoplasia
- Housing Grants Construction and Regeneration (UK; Office of Public Sector Information)
- Human Genetic Cell Repository (est. 1972; National Institute of General Medical Sciences)
- Housing Grants, Construction and Regeneration Act (1996, UK)
Samples in periodicals archive:
The findings to date from the ATHENA trial support the growing understanding that certain HPV genotypes are highly associated with the development of high-grade cervical intraepithelial neoplasia (CIN grade 2 or higher), a direct precursor to cervical cancer," said Dr.
Women who have had a total hysterectomy and no history of high-grade cervical intraepithelial neoplasia should discontinue cervical cancer screening altogether.
Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.
It is indicated to be used in conjunction with conventional Pap cytology testing as an aid to increase the sensitivity for the detection of high-grade cervical intraepithelial neoplasia.
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
The sensitivity of the Pap test to detect high-grade cervical intraepithelial neoplasia ([greater than or equal to]CIN2) ranges from 44% to 99% and specificity from 91 % to 98%.
Following successful completion of this Phase 1 trial, the Company anticipates launching a Phase 2 clinical trial with new HspE7 in patients with high-grade cervical intraepithelial neoplasia (CIN 2/3).